Picture of Aptinyx logo

APTX Aptinyx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Aptinyx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-53.3-57.4-50.1-74.9-64.8
Depreciation
Non-Cash Items3.329.049.989.928.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital2.06-4.17-2.71.02-3.76
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-47.4-52.1-42.4-63.4-59.7
Capital Expenditures-0.407-0.043-0.2140
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0040.1210
Sale of Fixed Assets
Cash from Investing Activities-0.407-0.039-0.2140.1210
Financing Cash Flow Items-3.24-0.182-0.68814.5-0.253
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1060.19284.728.39.75
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash58.5-51.942.1-35-49.9